Mayo Clinic Updates in Cancer Novel Immunotherapies 2023 - Abstract Submission
Thank you for your interest in submitting an abstract for consideration of a poster at the Mayo Clinic Updates in Cancer Novel Immunotherapies 2023 course. Please complete the fields below and click submit at the end of the form. If you do not receive a confirmation email, please look in your spam folder. 

Poster Abstract Deadline:
Abstracts will be accepted through August 11, 2023.

Abstract Eligibility:

  • Participants may be the primary author on no more than two abstracts; however, they may be a contributing author on any number of abstracts.
  • In support of inclusiveness, abstracts are not limited to first-time presentations. Abstracts that have been presented at previous meetings are eligible for consideration, as are abstracts from papers that have already been published.

Specific topics of interest: 

  • Cellular Therapy
  • Bi-Specific Antibody
  • Checkpoint Inhibitor
  • Other Immunotherapies

Submission Criteria

  • Create a profile if you have not done so already, then log into your account,
  • Complete and submit abstract form by August 11, 2023,
  • Abstracts are limited to 250 words,
  • Complete the form below,
  • Signatures required for all authors, prior to the submission being reviewed.

Requirements 

  • Conference will provide 4 x 4 ft. display board and push pins,
  • Poster presenters are expected to register for live attendance at the course to be held October 5-7, 2023, in Rochester, Minnesota. All costs associated with the presentation are the responsibility of the author(s),
  • Authors must stay with their posters during the assigned poster session(s),
  • Posters will be exhibited on Thursday, October 5,
  • All approved poster authors are required to submit a PDF of their poster to be electronically displayed to course attendees.

Requirements for the Top 4 Abstracts:

  • The judging panel will select the top 4 abstracts for oral presentation at the live course.
  • At least one author of selected abstracts will be invited to orally present their work at the live symposium.
  • The presentations may not exceed 10 minutes in length and will be followed by 5 min Q&A.
  • Registration fees will be waived for the selected top 4 abstracts and a travel grant will be offered. All other costs associated with the presentation are the responsibility of the author(s).

Notification of Results
All primary authors will be notified by August 21, 2023 if their submission has been selected for presentation.  Abstracts will be evaluated based on quality of the abstract, relevance to the conference theme, and impact.  Details regarding presentation will follow.  Questions can be directed to Kris Jones.